Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The need to better understand pathways that drive ER+ metastatic breast cancer

Published: 13.12.16
Views: 4236
Rating:

Dr Julie Gralow - University of Washington, Washington, USA

While many tumors in patients with ER /HER2- metastatic breast cancer respond to anti-estrogen therapy, almost all will eventually start to grow again despite the estrogen pathway being shut down. Therefore, there is a need to better understand the other pathways involved in tumor cell growth (Pfizer sponsored).

Visit breastcancervision.com to find out more about the global state of metastatic breast cancer and to learn
about the impact of breast cancer on women, please visit breastcancer-matters.eu.

Categories:

Breast · Medicines · Biology · Drug development

Related videos

follow us

Breast cancer epidemiology video


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation